EP13.03. Real-World Analysis of ICI Efficacy in ES-SCLC Patients with and without Brain Metastases: A Call for Inclusion in Clinical Trials - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Yuanzhen Cao
Meta Tag
Speaker Yuanzhen Cao
Topic SCLC & Neuroendocrine Tumors: First Line Therapy
immune checkpoint inhibitors
extensive stage small-cell lung cancer
brain metastases
clinical trials
overall survival
progression-free survival
radiographic response
intracranial response
Powered By